scholarly article | Q13442814 |
P356 | DOI | 10.3109/1040841X.2012.691870 |
P698 | PubMed publication ID | 22667455 |
P50 | author | Timothy R. Walsh | Q37834958 |
P2093 | author name string | Allaaeddin El Salabi | |
Chedly Chouchani | |||
P2860 | cites work | Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis | Q21246026 |
Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance | Q24548472 | ||
Efflux-mediated drug resistance in bacteria: an update | Q24609407 | ||
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Q24617818 | ||
Updated functional classification of beta-lactamases | Q24644798 | ||
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India | Q24647709 | ||
A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 | ||
Carbapenemases: the versatile beta-lactamases | Q24685034 | ||
Comparative genomics of multidrug resistance in Acinetobacter baumannii | Q25256737 | ||
Carbapenemases: a problem in waiting? | Q28142212 | ||
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin | Q28305833 | ||
Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance | Q28472615 | ||
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
Molecular basis of bacterial outer membrane permeability | Q29617897 | ||
Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme | Q31116674 | ||
Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion | Q33559180 | ||
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections | Q33580016 | ||
Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance | Q33747222 | ||
Metallo-beta-lactamases: the quiet before the storm? | Q33755227 | ||
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands | Q33876494 | ||
How antibiotics kill bacteria: from targets to networks | Q33958766 | ||
Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea | Q34123619 | ||
Antibiotics in the clinical pipeline in 2011. | Q34185670 | ||
The structure of β-lactamases | Q34246186 | ||
Pathogenicity islands in bacterial pathogenesis | Q34290188 | ||
Antimicrobial drug development--the past, the present, and the future | Q34364369 | ||
Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance | Q34541598 | ||
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. | Q41820620 | ||
blaVIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3' conserved sequence | Q41826663 | ||
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia | Q42012070 | ||
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States. | Q42111177 | ||
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital | Q42112179 | ||
Mobilizable genomic islands: going mobile with oriT mimicry | Q42695705 | ||
First report of the metallo-beta-lactamase SPM-1 in Europe. | Q42947072 | ||
Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa | Q43168664 | ||
In vitro analysis of ISEcp1B-mediated mobilization of naturally occurring beta-lactamase gene blaCTX-M of Kluyvera ascorbata | Q43261194 | ||
Tn5090-like class 1 integron carrying bla(VIM-2) in a Pseudomonas putida strain from Portugal | Q43313810 | ||
The coming of age of antibiotics: discovery and therapeutic value | Q48722585 | ||
Identification of plasmids by PCR-based replicon typing | Q50090387 | ||
Emerging epidemic of metallo-beta-lactamase-mediated resistances. | Q53871689 | ||
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. | Q54316090 | ||
Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. | Q55033593 | ||
Antimicrobial resistance in Irish isolates of verocytotoxigenic Escherichia coli (E. coli)—VTEC | Q57658397 | ||
Nosocomial outbreak of CTX-M-15-producing E. coli in Norway | Q57858738 | ||
Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons | Q57858879 | ||
Integrons: agents of bacterial evolution. | Q34569146 | ||
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections | Q34621459 | ||
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria | Q34969565 | ||
The future challenges facing the development of new antimicrobial drugs. | Q34988239 | ||
Ertapenem, the first of a new group of carbapenems | Q35209884 | ||
Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals | Q35220911 | ||
Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. | Q35364501 | ||
Carbapenems in Pediatrics | Q35543013 | ||
Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene | Q35685430 | ||
Genomic islands in pathogenic and environmental microorganisms | Q35752419 | ||
Translation and protein synthesis: macrolides | Q36034620 | ||
A survey of bacterial insertion sequences using IScan | Q36059490 | ||
Natural products--the future scaffolds for novel antibiotics? | Q36313566 | ||
OXA-type carbapenemases | Q36381840 | ||
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene | Q36538664 | ||
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 | ||
Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury | Q36593803 | ||
Comparative review of the carbapenems | Q36815085 | ||
High rate of mobilization for blaCTX-Ms | Q36944691 | ||
Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species | Q37071179 | ||
Resistance plasmid families in Enterobacteriaceae | Q37204254 | ||
Outer membrane permeability and antibiotic resistance | Q37227443 | ||
Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy. | Q37363749 | ||
The use of carbapenems in the treatment of serious infections | Q37555757 | ||
Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. | Q37624541 | ||
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices | Q37694529 | ||
Integrons. | Q37779789 | ||
Mobility of plasmids. | Q37784107 | ||
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae | Q37797732 | ||
Emerging carbapenemases: a global perspective | Q37815629 | ||
Combinatorial events of insertion sequences and ICE in Gram-negative bacteria | Q37897646 | ||
Molecular analysis of metallo-beta-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil | Q40706004 | ||
Superhelical Escherichia coli DNA: Relaxation by coumermycin | Q40881118 | ||
Common region CR1 for expression of antibiotic resistance genes | Q41474615 | ||
Preclinical class 1 integron with a complete Tn402-like transposition module. | Q41816938 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Gram-negative bacteria | Q632006 |
P304 | page(s) | 113-122 | |
P577 | publication date | 2012-06-06 | |
P1433 | published in | Critical Reviews in Microbiology | Q5186671 |
P1476 | title | Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria | |
P478 | volume | 39 |
Q28082463 | Active targeted drug delivery for microbes using nano-carriers |
Q57300031 | Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective |
Q44136876 | Antimicrobial resistance and genetic diversity in ceftazidime non-susceptible bacterial pathogens from ready-to-eat street foods in three Taiwanese cities |
Q40517063 | Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms |
Q64249700 | Comparative Metagenomics and Network Analyses Provide Novel Insights Into the Scope and Distribution of β-Lactamase Homologs in the Environment |
Q34702903 | Frequency and factors associated with carriage of multi-drug resistant commensal Escherichia coli among women attending antenatal clinics in central India |
Q38878917 | Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study |
Q89982963 | Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam |
Q48305623 | Metal tolerance assisted antibiotic susceptibility profiling in Comamonas acidovorans. |
Q33648385 | Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates |
Q41073121 | Multidrug resistance found in extended-spectrum beta-lactamase-producing Enterobacteriaceae from rural water reservoirs in Guantao, China |
Q39894471 | Multidrug-resistant phenotype and isolation of a novel SHV- beta-Lactamase variant in a clinical isolate of Enterobacter cloacae |
Q40082536 | Preliminary insights into the occurrence of similar clones of extended-spectrum beta-lactamase-producing bacteria in humans, animals and the environment in Tanzania: A systematic review and meta-analysis between 2005 and 2016. |
Q57490144 | Prevalence and Emergence of Extended-Spectrum Cephalosporin-, Carbapenem- and Colistin-Resistant Gram Negative Bacteria of Animal Origin in the Mediterranean Basin |
Q41372349 | Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from rural well water in Taian, China, 2014. |
Q30249131 | Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin |
Q38246106 | Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity |
Q60920666 | The Genetic Structures of an Extensively Drug Resistant (XDR) and Its Plasmids |
Q35209282 | The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods |
Q39851375 | The resistance and transmission mechanism of Acinetobacter baumannii isolates in a tertiary care hospital, China |
Q41991212 | pSY153-MDR, a p12969-DIM-related mega plasmid carrying blaIMP-45 and armA, from clinical Pseudomonas putida |
Search more.